- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 215/54 - Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
Patent holdings for IPC class C07D 215/54
Total number of patents in this class: 277
10-year publication summary
|
20
|
18
|
20
|
21
|
24
|
16
|
19
|
19
|
12
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 19479 |
8 |
| Syngenta Participations AG | 3039 |
8 |
| Araxes Pharma LLC | 89 |
8 |
| Ono Pharmaceutical Co., Ltd. | 437 |
8 |
| ClanoTech AB | 10 |
7 |
| Gilead Sciences, Inc. | 1949 |
7 |
| Bayer Animal Health GmbH | 229 |
6 |
| Neurocrine Biosciences, Inc. | 399 |
6 |
| Regenacy Pharmaceuticals, LLC | 30 |
6 |
| Grünenthal GmbH | 599 |
5 |
| Inflarx GmbH | 45 |
5 |
| Vertex Pharmaceuticals Incorporated | 1570 |
4 |
| Imago Biosciences, Inc. | 37 |
4 |
| Neuronascent, Inc. | 16 |
4 |
| The Research Foundation for The State University of New York | 1547 |
4 |
| Firmenich Incorporated | 136 |
4 |
| Bristol-myers Squibb Company | 4886 |
3 |
| Janssen Pharmaceutica N.V. | 3625 |
3 |
| Monsanto Technology LLC | 8078 |
3 |
| Sunshine Lake Pharma Co., Ltd. | 567 |
3 |
| Other owners | 171 |